Latest news
Claris Bio raises $118M to advance first-ever LSCD therapy - Glance by Eyes On EyecareGlance by Eyes On Eyecare · Mon, 03 Aug 2026 19:26:06 GMTClaris Bio Raises $118M to Take Eye Drop for Blindness into Phase III - Inside Precision MedicineInside Precision Medicine · Wed, 29 Jul 2026 18:58:34 GMTClaris Bio raises $118m for eye disease therapy - BioXconomyBioXconomy · Wed, 29 Jul 2026 07:00:00 GMTAn eye drug biotech banks $118M and stocks its executive suite - BioPharma DiveBioPharma Dive · Tue, 28 Jul 2026 07:00:00 GMTClaris Bio raises USD 118m to advance first-ever pharmacologic therapy for limbal stem cell deficiency - AllSciAllSci · Tue, 28 Jul 2026 07:00:00 GMTClaris Bio Unveils Development Strategy, Planned Pivotal Study Supported by $118 Million Series B Financing from Top-Tier Investors, and Multiple Leadership Appointments - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 07:00:00 GMT